Drug · DIN 02537427
MINT-FINASTERIDE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since May 15, 2024; first marketed May 15, 2024.
- Drug Identification Number (DIN)
- 02537427
- Company (DIN owner)
- Mint Pharmaceuticals IncMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Finasteride D11AX10
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| FINASTERIDE | 1 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 25, 2023: NOC 30566Abbreviated New Drug Submission (ANDS)
Other DINs named MINT-FINASTERIDE
- DIN 02389878 · Marketed